Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroupsNature (London), 2019-03, Vol.567 (7748), p.399-404 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Mar 21, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1007-8 ;PMID: 30867590Full text available |
|
2 |
Material Type: Article
|
Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas SocietyJournal of gastroenterology, 2020-01, Vol.55 (1), p.86-99 [Peer Reviewed Journal]Japanese Society of Gastroenterology 2019 ;COPYRIGHT 2020 Springer ;Journal of Gastroenterology is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0944-1174 ;EISSN: 1435-5922 ;DOI: 10.1007/s00535-019-01617-2 ;PMID: 31463655Full text available |
|
3 |
Material Type: Article
|
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic RecurrenceClinical cancer research, 2019-07, Vol.25 (14), p.4255-4263 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-3663 ;PMID: 30992300Full text available |
|
4 |
Material Type: Article
|
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisJNCI : Journal of the National Cancer Institute, 2018-06, Vol.110 (6), p.560-567 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djy018 ;PMID: 29659933Full text available |
|
5 |
Material Type: Article
|
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate CancerClinical cancer research, 2019-12, Vol.25 (24), p.7448-7454 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-1050 ;PMID: 31511295Full text available |
|
6 |
Material Type: Article
|
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisThe lancet oncology, 2013-11, Vol.14 (12), p.1200-1207 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2013 ;2013 Elsevier Ltd. All rights reserved 2013 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70449-2 ;PMID: 24140199 ;CODEN: LANCAOFull text available |
|
7 |
Material Type: Article
|
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trialThe lancet oncology, 2016-06, Vol.17 (6), p.738-746 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)00150-9 ;PMID: 27108243 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Article
|
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialThe lancet oncology, 2021-04, Vol.22 (4), p.450-462 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30737-3 ;PMID: 33794205Full text available |
|
9 |
Material Type: Article
|
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New TherapiesCA: a cancer journal for clinicians, 2018-11, Vol.68 (6), p.488-505 [Peer Reviewed Journal]2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21498 ;PMID: 30328620Full text available |
|
10 |
Material Type: Article
|
From normal response to clinical problem: definition and clinical features of fear of cancer recurrenceSupportive care in cancer, 2016-08, Vol.24 (8), p.3265-3268 [Peer Reviewed Journal]Springer-Verlag Berlin Heidelberg 2016 ;COPYRIGHT 2016 Springer ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-016-3272-5 ;PMID: 27169703Full text available |
|
11 |
Material Type: Article
|
Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancerJournal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.1396-1405 [Peer Reviewed Journal]2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14042 ;PMID: 30467945Full text available |
|
12 |
Material Type: Article
|
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity (Cambridge, Mass.), 2013-10, Vol.39 (4), p.782-795 [Peer Reviewed Journal]2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 17, 2013 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2013.10.003 ;PMID: 24138885Full text available |
|
13 |
Material Type: Article
|
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)Nature medicine, 2021-02, Vol.27 (2), p.301-309 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-01188-3 ;PMID: 33558722Full text available |
|
14 |
Material Type: Article
|
Hepatocellular carcinoma: clinical frontiers and perspectivesGut, 2014-05, Vol.63 (5), p.844-855 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2013-306627 ;PMID: 24531850 ;CODEN: GUTTAKFull text available |
|
15 |
Material Type: Article
|
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaClinical cancer research, 2021-02, Vol.27 (4), p.1048-1057 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-2500 ;PMID: 33199490Full text available |
|
16 |
Material Type: Article
|
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv19-iv29 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy080 ;PMID: 29796651Full text available |
|
17 |
Material Type: Article
|
Overcoming therapeutic resistance in glioblastoma: the way forwardThe Journal of clinical investigation, 2017-02, Vol.127 (2), p.415-426 [Peer Reviewed Journal]COPYRIGHT 2017 American Society for Clinical Investigation ;COPYRIGHT 2017 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Feb 2017 ;Copyright © 2017, American Society for Clinical Investigation 2017 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci89587 ;PMID: 28145904Full text available |
|
18 |
Material Type: Article
|
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancerAnnals of oncology, 2019-11, Vol.30 (11), p.1804-1812 [Peer Reviewed Journal]2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz390 ;PMID: 31562764Full text available |
|
19 |
Material Type: Article
|
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical responseBlood, 2017-08, Vol.130 (6), p.732-741 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-04-779447 ;PMID: 28588019Full text available |
|
20 |
Material Type: Article
|
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinomaJ. Hepatol, 2019-01, Vol.70 (1), p.58-65 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;DOI: 10.1016/j.jhep.2018.09.003 ;PMID: 30213589Digital Resources/Online E-Resources |